Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00934141 · ClinicalTrials.gov registry record · Phase 3
Evaluating Improvement Strategies in Addiction Treatment
A Phase 3 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 3
- Development phase
- 201
- Enrollment target
NCT00934141 is a Phase 3 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 201 participants.
The verdict
NCT00934141, a Phase 3 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 201 participants
- Enrollment target
Study Summary
Addiction treatment is often characterized by long delays between first contact and treatment as well as high no-show and drop out rates leading to unused capacity in apparently full agencies. Patients do not get needed care and agency financial stability is threatened. The Network for Improvement of Addiction Treatment (NIATx) began as a high-intensity improvement collaborative of 39 addiction treatment agencies distributed across 25 states. NIATx substantially improved time to treatment and continuation in treatment by making improvements to organizational processes (such as first contact, intake and assessment, engagement, level of care transitions, paperwork, social support, outreach, and scheduling) in preliminary studies. While the results are very encouraging, they have, by intent, been obtained from a select group of agencies using a high-cost combination of services. A more practical diffusion model is needed to spread process improvements across the spectrum of treatment agencies. This study is a cluster-randomized trial to test the effectiveness and cost of less expensive combinations of the services that make up the NIATx collaborative (interest circles, coach calls, coach visits and learning sessions).
Interventions
- OTHER Coaching
- OTHER Learning Session
- OTHER Interest Circle Calls
- OTHER Website
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2006-10 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00934141
The ClinicalTrials.gov registry entry for NCT00934141 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Coaching is the first listed.
NCT00934141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00934141 about?
NCT00934141 is a clinical study titled "Evaluating Improvement Strategies in Addiction Treatment". Addiction treatment is often characterized by long delays between first contact and treatment as well as high no-show and drop out rates leading to unused capacity in apparently full agencies. Patients do not get needed care and agency financial stability is threatened. The Network for Improvement o...
What is the current status of trial NCT00934141?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 201 participants. The study started on 2006-10. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00934141?
The interventions under investigation include: Coaching (OTHER), Learning Session (OTHER), Interest Circle Calls (OTHER), Website (OTHER).
Who is sponsoring clinical trial NCT00934141?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.